We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Top Buys

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$17.2M
2
SPR
Spirit AeroSystems
SPR
+$15.4M
3
BABA icon
Alibaba
BABA
+$12.1M
4
NFLX icon
Netflix
NFLX
+$11.9M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$8.12M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$9.18M
2
EE
El Paso Electric Company
EE
+$8.45M
3
IBKC
IBERIABANK Corp
IBKC
+$7.95M
4
CZR
Caesars Entertainment Corporation
CZR
+$7.02M
5
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
+$6.27M

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNKO icon
1576
Funko
FNKO
$335M
$4K ﹤0.01%
+670
New +$3.93K
FONR
1577
DELISTED
Fonar
FONR
$4K ﹤0.01%
+200
New +$4.82K
HOOK
1578
DELISTED
HOOKIPA Pharma
HOOK
$4K ﹤0.01%
39
+20
+105% +$2.04K
IMKTA icon
1579
Ingles Markets
IMKTA
$1.68B
$4K ﹤0.01%
+100
New +$4.03K
MCS icon
1580
Marcus Corp
MCS
$929M
$4K ﹤0.01%
+504
New +$6.79K
MLKN icon
1581
MillerKnoll
MLKN
$1.62B
$4K ﹤0.01%
130
-1,017
-89% -$25.2K
OOMA icon
1582
Ooma
OOMA
$574M
$4K ﹤0.01%
300
+33
+12% +$503
PSEC icon
1583
Prospect Capital
PSEC
$1.18B
$4K ﹤0.01%
+800
New +$4.02K
SFBS
1584
ServisFirst Bancshares
SFBS
$5B
$4K ﹤0.01%
+130
New +$4.67K
SNDX icon
1585
Syndax Pharmaceuticals
SNDX
$1.7B
$4K ﹤0.01%
+300
New +$4.57K
VTR icon
1586
CALL
Ventas
VTR
$46.3B
$4K ﹤0.01%
100
– –
ACCS
1587
ACCESS Newswire
ACCS
$18.7M
$4K ﹤0.01%
+200
New +$3K
VBIV
1588
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$4K ﹤0.01%
+43
New +$5.01K
DMK
1589
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$4K ﹤0.01%
+79
New +$4.68K
ICPT
1590
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4K ﹤0.01%
100
-200
-67% -$9.19K
DBD
1591
DELISTED
Diebold Nixdorf Incorporated
DBD
$4K ﹤0.01%
522
-603
-54% -$4.43K
CSII
1592
DELISTED
Cardiovascular Systems, Inc.
CSII
$4K ﹤0.01%
+100
New +$3.23K
SRNE
1593
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4K ﹤0.01%
400
-300
-43% -$2.75K
OYST
1594
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$4K ﹤0.01%
+200
New +$4.68K
GTS
1595
DELISTED
Triple-S Management Corporation
GTS
$4K ﹤0.01%
+200
New +$3.76K
DRNA
1596
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4K ﹤0.01%
200
-3,300
-94% -$68.3K
MXIM
1597
DELISTED
Maxim Integrated Products
MXIM
$4K ﹤0.01%
+58
New +$3.92K
CNST
1598
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4K ﹤0.01%
+200
New +$4.88K
CBMG
1599
CALL
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$4K ﹤0.01%
+200
New +$3.36K
AKCA
1600
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
$4K ﹤0.01%
+200
New +$2.84K
62 63
64
65 66

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.